Andrew Hendifar, Md
Clinical trials sponsored by Andrew Hendifar, Md, explained in plain language.
-
Enzyme therapy aims to fight wasting in pancreatic cancer patients
Disease control OngoingThis study tests whether adding a high-dose pancreatic enzyme replacement (Pancreaze) to standard care can help patients with advanced pancreatic cancer who have weight loss and trouble digesting food. About 36 adults will take the enzymes with meals and snacks for 8 weeks. The g…
Phase: PHASE2 • Sponsor: Andrew Hendifar, MD • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can an Anti-Inflammatory drug help pancreatic cancer patients keep weight on?
Symptom relief OngoingThis study looks at whether ketorolac, a common anti-inflammatory drug, is safe and can help stabilize or increase weight in people with advanced pancreatic cancer who are experiencing cachexia (severe weight loss). About 28 participants will take the drug four times daily for fi…
Phase: EARLY_PHASE1 • Sponsor: Andrew Hendifar, MD • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC